Database Query Results : , , Imm
Imm, immunostimulatory: Click to Expand ⟱
| Source: |
| Type: |
Enhance the immune response in patients.
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, EMT↓, AntiCan↑, *cardioP↑, *neuroP↑, TumCG↓, *antiOx↑, *Bacteria↓, *Imm↑, *hepatoP↑, *AntiDiabetic↑, ROS↓, *chemoPv↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
PSA, |
NA |
|
|
|
ROS↑, ER Stress↑, TumCG↓, Apoptosis↑, Inflam↓, ChemoSen↑, Casp↑, ERK↓, cl‑PARP↑, AR↓, cycD1/CCND1↓, VEGFR2↓, CXCR4↓, radioP↑, NF-kB↓, VEGF↓, P21↑, Wnt↓, β-catenin/ZEB1↓, Cyt‑c↑, MMP2↓, MMP1↓, MMP9↓, PI3K↓, MAPK↓, JNK↑, *5LO↓, *NRF2↑, *HO-1↑, *MDA↓, *SOD↑, *hepatoP↑, *ALAT↓, *AST↓, *LDH↑, *CRP↓, *COX2↓, *GSH↑, *ROS↓, *Imm↑, *Dose↝, *eff↑, *neuroP↑, *cognitive↑, *IL6↓, *TNF-α↓,
AntiTum↑, eff↑, ALDH↓, Dose↝, RadioS↑, angioG↓, TumMeta↓, BioAv↝, ROS↑, DNAdam↑, P-gp↓, CSCs↓, EMT↓, Imm↑, SOD↓, MAPK↓, NF-kB↓, ChemoSen↑, eff↑, toxicity↝, BioAv↑, *Inflam↓, Sepsis↓,
TumCP↓, TumCMig↓, TumCI↓, eff↑, Imm↑, ROS↑, NF-kB↓, chemoP↑, JNK↑, FOXO↑, Myc↑, TumCCA↑, Apoptosis↑, RadioS↑, PD-L1↑, eff↑, CSCs↓, Dose↝, Half-Life↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
*toxicity↝, *toxicity↓, *other↝, ROS↑, *Dose↝, *selenoP↑, AntiCan↑, AntiTum↑, *Bacteria↓, *radioP↑, *BioAv↑, *Inflam↓, *Imm↑, ChemoSen↑, *AntiAg↑, selectivity↑, eff↑, other↝, *eff↑, *Aβ↓, *eff↑,
AntiCan↑, Imm↑, *AntiDiabetic↑, *antiOx↑, *Inflam↓, ROS↑, ER Stress↑, DNAdam↑, *toxicity↓, *eff↑, *BioAv↑, selectivity↑, TumCCA↑, Risk↓, *lipid-P↓, *TNF-α↓, *CRP↓, TumMeta↓, angioG↓, selectivity↑, eff↑, *eff↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
Sepsis, |
NA |
|
|
|
*antiOx↓, *Inflam↓, Risk↓, TumCI↓, TumMeta↓, radioP↑, chemoP↑, Apoptosis↑, ROS↑, DNAdam↑, Dose↑, selectivity↑, *other↓, *BioAv↑, ROS↑, MMP↓, Casp↑, *Imm↑, *Pain↓, Sepsis↓, MMP2↓, MMP9↓, *Half-Life↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*Imm↑, *GutMicro↑, *BioAv↑, *Risk↓, *Dose↝, Risk↓, *CRP↓, *GPx↓, *Inflam↓, *selenoP↑, *Dose↝, *ROS↓, *MDA↓, *SOD↑, *GPx↑, *IL1↓, *MCP1↓, *IL6↓, *TNF-α↓, Risk↓, *neuroP↑, *memory↑,
*antiOx↑, chemoPv↑, ROS↑, Imm↑, selenoP↑, *IL2↑, *IL4↑, *TNF-α↓, *TGF-β↓, *EMT↓, Risk↓, *GPx↑, *TrxR↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
BioAv↝, TumAuto↝, TumCG↓, TumMeta↓, ChemoSen↑, Imm↑, RadioS↑, BioAv↑, other↝, eff↓, *antiOx↓, *Inflam↓, AntiCan↓, AntiAge↑, chemoP↑, *neuroP↑, *ROS↓, *cognitive↑, *lipid-P↓, *cardioP↑, *TNF-α↓, *IL6↓, GutMicro↑, TumCCA↑, Apoptosis↑, angioG↓, NF-kB↓, PI3K↓, Akt↓, Casp↑, survivin↓, TumCP↓, cycD1/CCND1↓, cMyc↑, BAX↑, Bcl-2↓, COX2↓, P53↑, p38↑, *ROS↓, *SOD↑, *GPx↑, SIRT1↑, FOXO1↑, eff↑, ChemoSen↑,
AntiTum↑, *Imm↑, AntiCan↑,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
chemoPv↑, 1,
Redox & Oxidative Stress ⓘ
ROS↓, 1, ROS↑, 8, selenoP↑, 1, SOD↓, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↑, 1, SIRT1↑, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 5, BAX↑, 1, Bcl-2↓, 1, Casp↑, 3, Cyt‑c↑, 1, JNK↑, 2, MAPK↓, 2, Myc↑, 1, p38↑, 1, survivin↓, 1,
Transcription & Epigenetics ⓘ
other↝, 2,
Protein Folding & ER Stress ⓘ
ER Stress↑, 2,
Autophagy & Lysosomes ⓘ
TumAuto↝, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 3, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 2, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
ALDH↓, 1, CSCs↓, 2, EMT↓, 2, ERK↓, 1, FOXO↑, 1, FOXO1↑, 1, PI3K↓, 2, TumCG↓, 3, Wnt↓, 1,
Migration ⓘ
MMP1↓, 1, MMP2↓, 2, MMP9↓, 2, TumCI↓, 2, TumCMig↓, 1, TumCP↓, 2, TumMeta↓, 4, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 3, VEGF↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling Immune Signaling & Inflammation group includes innate and adaptive immune pathways, cytokines, chemokines, pattern-recognition receptors, complement, and inflammasomes. It regulates host defense, tumor immunity, neuroinflammation, and chron" style="cursor:help;color:#555;font-weight:normal;">ⓘ
COX2↓, 1, CXCR4↓, 1, Imm↑, 5, Inflam↓, 1, NF-kB↓, 4, PD-L1↑, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 2, BioAv↝, 2, ChemoSen↑, 5, Dose↑, 1, Dose↝, 2, eff↓, 1, eff↑, 7, Half-Life↑, 1, RadioS↑, 3, selectivity↑, 4,
Clinical Biomarkers ⓘ
AR↓, 1, GutMicro↑, 1, Myc↑, 1, PD-L1↑, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiCan↓, 1, AntiCan↑, 4, AntiTum↑, 3, chemoP↑, 3, radioP↑, 2, Risk↓, 5, toxicity↝, 1,
Infection & Microbiome ⓘ
Sepsis↓, 2,
Total Targets: 79
Pathway results for Effect on Normal Cells:
NA, unassigned ⓘ
chemoPv↑, 1,
Redox & Oxidative Stress ⓘ
antiOx↓, 2, antiOx↑, 3, GPx↓, 1, GPx↑, 3, GSH↑, 1, HO-1↑, 1, lipid-P↓, 2, MDA↓, 2, NRF2↑, 1, ROS↓, 4, selenoP↑, 2, SOD↑, 3, TrxR↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, LDH↑, 1,
Transcription & Epigenetics ⓘ
other↓, 1, other↝, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1,
Migration ⓘ
5LO↓, 1, AntiAg↑, 1, TGF-β↓, 1,
Immune & Inflammatory Signaling Immune Signaling & Inflammation group includes innate and adaptive immune pathways, cytokines, chemokines, pattern-recognition receptors, complement, and inflammasomes. It regulates host defense, tumor immunity, neuroinflammation, and chron" style="cursor:help;color:#555;font-weight:normal;">ⓘ
COX2↓, 1, CRP↓, 3, IL1↓, 1, IL2↑, 1, IL4↑, 1, IL6↓, 3, Imm↑, 6, Inflam↓, 6, MCP1↓, 1, TNF-α↓, 5,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 4, Dose↝, 4, eff↑, 5, Half-Life↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1, CRP↓, 3, GutMicro↑, 1, IL6↓, 3, LDH↑, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 2, cardioP↑, 2, cognitive↑, 2, hepatoP↑, 2, memory↑, 1, neuroP↑, 4, Pain↓, 1, radioP↑, 1, Risk↓, 1, toxicity↓, 2, toxicity↝, 1,
Infection & Microbiome ⓘ
Bacteria↓, 2,
Total Targets: 55
Scientific Paper Hit Count for: Imm, immunostimulatory
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1332 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page